Mogrol, an aglycone of mogrosides, attenuates ulcerative colitis by promoting AMPK activation

Medicine and Dentistry

• Ulcerative Colitis 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Kinase 100%
• Tumor Necrosis Factor 66%
• Study Design 50%
• Western Blot 50%
• Cells 33%
• Signal Transduction 33%
• Lipopolysaccharide 33%
• Real-Time Polymerase Chain Reaction 33%
• Inflammatory Mediator 33%
• Dextran Sulfate 33%
• NLRP3 Inflammasome 33%
• Aglycone 33%
• Incidence 16%
• In Vitro 16%
• Evaluation Study 16%
• Biological Activity 16%
• Histology 16%
• Epithelial Cell 16%
• Oral Drug Administration 16%
• Adenosine Triphosphate 16%
• Colon Mucosa 16%
• Microfold Cell 16%
• Immunofluorescence Test 16%
• Experimental Ulcerative Colitis 16%
• Macrophage 16%
• Protein Kinase Inhibitor 16%

Biochemistry, Genetics and Molecular Biology

• AMP-activated Protein Kinase 100%
• Signal Transduction 33%
• Mediator 33%
• Dextran 33%
• Lipopolysaccharide 33%
• Sodium Sulfate 33%
• Aglycone 33%
• Mouse 16%
• Biological Activity 16%
• Incidence 16%
• Adenosine Triphosphate 16%
• Colon Mucosa 16%
• Immunofluorescence 16%
• Oxygenation 16%
• Staining 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Hydroxymethylglutaryl Coenzyme A Reductase Kinase 100%
• Ulcerative Colitis 100%
• Lipopolysaccharide 33%
• Anti-Inflammatory Drug 33%
• Dextran Sulfate 33%
• Aglycone 33%
• Incidence 16%
• Mouse 16%
• Inflammatory Disease 16%
• Adenosine Triphosphate 16%
• Protein Kinase Inhibitor 16%